New studies have found that some biomarkers, such as ITGA-5 and Tenascin-C, could predict glioma prognosis, and are closely related to the immunosuppressive microenvironment, particularly for the clinical application of immunotherapy in glioma (26, 27). The gene discussed is ITGA5; the disease is glioma.